Praxis Precision Medicines, Inc. (PRAX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Praxis Precision Medicines, Inc. (PRAX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

PRAX Income Statement

Praxis Precision Medicines, Inc. (PRAX) annual income statement — 8-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	7.46M	302K	357K	431K	515K	468K	781K	683K	0	0	0	0	0	0
Revenue Growth %	-	-	-100%	-100%	-100%	-100%	1349.13%	-35.47%	-54.29%	-36.9%	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	39K	77.51M	65.8M	63.01M	60.81M	56.29M	41.88M	27.26M	26.98M	18.39M	17.26M	25.61M	25.5M	27.73M	30.44M	2.99M	52.65M	0	0
COGS % of Revenue	-	-	-	-	-	-	754.23%	13867.88%	7635.85%	6260.79%	3570.49%	3688.03%	3279.64%	3734.11%	-	-	-	-	-	-
Gross Profit	0	-39K	-77.51M	-65.8M	-63.01M	-60.81M	-48.83M	-41.58M	-26.9M	-26.55M	-17.87M	-16.79M	-24.83M	-24.82M	-27.73M	-30.44M	-2.99M	-52.65M	0	0
Gross Margin %	-	-	-	-	-	-	-654.23%	-13767.88%	-7535.85%	-6160.79%	-3470.49%	-3588.03%	-3179.64%	-3634.11%	-	-	-	-	-	-
Gross Profit Growth %	100%	99.94%	-58.74%	-58.25%	-134.2%	-129%	-173.18%	-147.61%	-8.34%	-6.98%	35.54%	44.83%	-731.37%	52.86%	-	-	-	-	-	-
Operating Expenses	96.9M	105.86M	19.54M	12.56M	13.06M	13.92M	15.13M	15.26M	10.59M	15.33M	9.93M	8.72M	10.13M	13.27M	13.72M	13.85M	57.41M	16.2M	58.66M	44.77M
OpEx % of Revenue	-	-	-	-	-	-	202.75%	5051.66%	2964.99%	3557.54%	1928.74%	1864.1%	1296.67%	1942.9%	-	-	-	-	-	-
Selling, General & Admin	27.49M	27.87M	19.54M	12.56M	13.06M	13.92M	15.13M	15.26M	10.59M	15.33M	9.93M	8.72M	10.13M	13.27M	12.72M	13.85M	16.37M	16.2M	15.15M	11.63M
SG&A % of Revenue	-	-	-	-	-	-	202.75%	5051.66%	2964.99%	3557.54%	1928.74%	1864.1%	1296.67%	1942.9%	-	-	-	-	-	-
Research & Development	69.42M	77.99M	77.51M	65.8M	63.01M	60.81M	56.29M	41.88M	27.26M	26.98M	18.39M	17.26M	25.61M	25.5M	28.33M	30.44M	43.62M	52.65M	43.51M	33.14M
R&D % of Revenue	-	-	-	-	-	-	754.23%	13867.88%	7635.85%	6260.79%	3570.49%	3688.03%	3279.64%	3734.11%	-	-	-	-	-	-
Other Operating Expenses	0	0	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	0	0
Operating Income	-96.9M	-105.86M	-97.04M	-78.36M	-76.07M	-74.73M	-63.96M	-56.84M	-37.49M	-41.89M	-27.81M	-25.52M	-34.96M	-38.09M	-41.45M	-44.29M	-60.39M	-68.85M	-58.66M	-44.77M
Operating Margin %	-	-	-	-	-	-	-856.97%	-18819.54%	-10500.84%	-9718.33%	-5399.22%	-5452.14%	-4476.31%	-5577.01%	-	-	-	-	-	-
Operating Income Growth %	-27.39%	-41.66%	-51.74%	-37.87%	-102.91%	-78.41%	-130.01%	-122.74%	-7.23%	-9.96%	32.92%	42.39%	42.11%	44.67%	29.33%	1.08%	-65.54%	-151.1%	-128.13%	-
EBITDA	-96.87M	-105.82M	-97.02M	-78.34M	-76.02M	-74.68M	-63.91M	-56.74M	-37.38M	-41.77M	-27.7M	-25.41M	-34.85M	-37.98M	-41.35M	-44.19M	-60.27M	-68.76M	-58.56M	-44.73M
EBITDA Margin %	-	-	-	-	-	-	-856.34%	-18789.07%	-10470.87%	-9692.34%	-5377.67%	-5428.85%	-4462.74%	-5561.49%	-	-	-	-	-	-
EBITDA Growth %	-27.43%	-41.7%	-51.8%	-38.06%	-103.37%	-78.77%	-130.76%	-123.34%	-7.25%	-9.98%	33.02%	42.5%	42.18%	44.75%	29.4%	1.22%	-65.34%	-150.97%	-127.95%	-
D&A (Non-Cash Add-back)	33K	39K	28K	19K	46K	47K	47K	92K	107K	112K	111K	109K	106K	106K	105K	102K	119K	93K	93K	39K
EBIT	-83.72M	-92.56M	-88.91M	-73.93M	-71.13M	-69.3M	-58.68M	-51.91M	-32.68M	-39.55M	-27.81M	-25.52M	-34.96M	-38.09M	-40.45M	-44.29M	-59.39M	-68.85M	-58.66M	-44.77M
Net Interest Income	0	13.3M	0	0	4.94M	0	0	0	0	0	822K	884K	648K	636K	0	0	200K	0	0	0
Interest Income	0	13.3M	0	0	4.94M	0	0	0	0	0	928K	884K	648K	636K	0	0	200K	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	106K	0	0	0	0	0	0	0	0	0
Other Income/Expense	13.18M	13.3M	8.13M	4.42M	4.94M	5.43M	5.28M	4.92M	4.81M	2.33M	928K	884K	648K	636K	280K	345K	200K	132K	70K	73K
Pretax Income	-83.72M	-92.56M	-88.91M	-73.93M	-71.13M	-69.3M	-58.68M	-51.91M	-32.68M	-39.55M	-26.88M	-24.63M	-34.31M	-37.45M	-41.17M	-43.95M	-60.19M	-68.72M	-58.59M	-44.7M
Pretax Margin %	-	-	-	-	-	-	-786.27%	-17188.74%	-9153.22%	-9177.03%	-5219.03%	-5263.25%	-4393.34%	-5483.89%	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-5K	5K
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0.01%	-0.01%
Net Income	-83.72M	-92.56M	-88.91M	-73.93M	-71.13M	-69.3M	-58.68M	-51.91M	-32.68M	-39.55M	-26.88M	-24.63M	-34.31M	-37.45M	-41.17M	-43.95M	-60.19M	-68.72M	-58.58M	-44.7M
Net Margin %	-	-	-	-	-	-	-786.27%	-17188.74%	-9153.22%	-9177.03%	-5219.03%	-5263.25%	-4393.34%	-5483.89%	-	-	-	-	-	-
Net Income Growth %	-17.71%	-33.57%	-51.52%	-42.43%	-117.67%	-75.2%	-118.32%	-110.74%	4.77%	-5.6%	34.72%	43.95%	43%	45.49%	29.72%	1.7%	-65.36%	-151.04%	-127.89%	-
Net Income (Continuing)	-83.72M	-92.56M	-88.91M	-73.93M	-71.13M	-69.3M	-58.68M	-51.91M	-32.68M	-39.55M	-26.88M	-24.63M	-34.31M	-37.45M	-41.17M	-43.95M	-60.19M	-68.72M	-58.58M	-44.7M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-2.87	-3.20	-3.50	-3.36	-3.31	-3.29	-2.94	-2.75	-1.74	-2.84	-2.97	-2.72	-7.38	-10.58	-12.89	-14.29	-19.76	-22.63	-19.54	-15.00
EPS Growth %	13.29%	2.74%	-19.05%	-22.18%	-90.23%	-15.85%	1.01%	-1.1%	76.42%	73.16%	76.96%	80.97%	62.65%	53.25%	34.03%	4.73%	-50.5%	-112.09%	-55.57%	-
EPS (Basic)	-2.87	-3.20	-3.52	-3.36	-3.31	-3.29	-2.94	-2.75	-1.74	-2.84	-2.97	-2.72	-7.38	-10.58	-12.89	-14.29	-19.76	-22.63	-19.54	-15.00
Diluted Shares Outstanding	29.13M	28.88M	22.5M	21.98M	21.47M	21.06M	19.98M	18.88M	18.82M	13.9M	9.06M	9.04M	4.65M	3.54M	3.17M	3.05M	3.04M	3.03M	3M	2.98M
Basic Shares Outstanding	29.13M	28.88M	22.5M	21.98M	21.47M	21.06M	19.98M	18.88M	18.82M	13.9M	9.06M	9.04M	4.65M	3.54M	3.17M	3.05M	3.04M	3.03M	3M	2.98M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-